Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis

Fig. 3

a Box plot showing the association between fecal calprotectin and frequency of NSAID intake at 5-year follow-up. b Box plot showing the distribution of fecal calprotectin among patients on anti-TNF antibodies (infliximab, adalimumab, golimumab) vs. no TNF blocker therapy vs. TNF receptor fusion proteins (etanercept) at 5-year follow-up. Values are median (horizontal lines), IQR (boxes), and total range (whiskers). NSAID Nonsteroidal anti-inflammatory drug, TNF Tumor necrosis factor

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us